Helus psychedelic depression drug shows efficacy but safety concerns emerge
Published 2 d ago1 sourceEvidence: Reported
Sanofi has begun recruiting adults aged 18-45 for two clinical studies of an experimental mRNA-based acne vaccine, assessing safety, immunogenicity, and efficacy. The candidate targets a common chronic skin condition with no approved vaccine, but early-stage data and timelines remain undisclosed. This is a notable pipeline development for Sanofi's mRNA platform, though far from market approval.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 13 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 19 h ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported